The market for nanopharmaceuticals has evolved on the back of the advances in drug delivery technologies. The drive for novel drug delivery systems has helped expand the potential in the market and pave way to prevention, treatment, and diagnosis of diseases. Strides made by nanomedicine has helped expand the application of nanopharmaceuticals in therapeutics for a range of treatments. Drug makers have for long been grappling with toxic systemic affects in patients. World over, they have been leveraging the potential of nanopharmaceuticals for site-specific targeting in patient populations, increasing the compliance. Pressing need for advances in drug target discovery is a key trend boosting the market. In the coming years, cost effective products will see new markets on account of demands for stimulus-sensitive targeted therapy. Growing body of clinical trials on nanocomponents has been underpinning the growing potential of pharmaceuticals to reap revenues. This has paved way to new nanopharmaceuticals formulations. A handful of these, however, have been able to bag regulatory approvals.
The size of the nanopharmaceuticals market is dependent on several factors such as possibility of market failure, cost concerns, and the scope of commercial development of nano-based pharmaceutical products. One of the most promising application areas that are showing vast potential is brain-targeted drug delivery. Researchers have been relentlessly working to equip nanopharmaceuticals with functional modalities and achieve active targeting to the brain tissues and overcome blood-brain barrier. The compelling propositions are reduced amount of dose and precision targeting of the central nervous system. In this regard, the market is seeing new opportunities in drug-loaded nanocarriers equipped with physicochemical properties. Key types of nanopharmaceuticals in used in brain-targeted drug delivery comprise, lipidic, amphiphilic, and polymeric nanocarriers. Future growth prospects of the nanopharmaceuticals market are expected to be shaped by stringent regulations for their safety and efficacy. This will also decide the course of private investments, especially in emerging markets.
Global Nanopharmaceuticals Market: An Overview
The global nanopharmaceuticals is expected to garner a stellar growth in the forecast period. This is mainly due to increasing prevalence of chronic diseases such as cancer, infectious diseases, cardiovascular diseases and other diseases.
Nanopharmaceuticals can be elaborated as Nanotechnology-based pharmaceuticals. They are known for offering potential solutions to fundamental problems of patients in the drug industry. With further research and development activities, the cost of nanopharmaceuticals drugs is expected to reduce. However, there are a few hurdles which need to be overcome before nanopharmaceuticals become an integral part of modern medicine.
Nanopharmaceuticals are particles of 10 to 1,000 nanometers that are used for drug manufacturing. Owing to their diverse shape and composition, they are have several benefits over their counterparts.
Global Nanopharmaceuticals Market: Notable Developments
The researchers in the nanopharmaceuticals market are working on a drug called Camptothecin. This nanopharmaceuticals has ability to inhibit of topoisomerase which is used for treatment of cancer. The drug was unsuccessful due to poor drug solubility. In order to address this issue, scientists are working on polymeric nanoparticle comprised of cyclodextrin-poly(ethylene glycol) copolymer (CDP) conjugated to CPT (CRLX101. This is expected to offer further opportunities in the nanapharmaceuticals market.
Global Nanopharmaceuticals Market: Key Trends
The global nanopharmaceuticals market is expected to rise at a significant pace during the forecast period. This is mainly due the increasing research and development activities for discovery of new products.
Major players in the nanopharmaceuticals market are ramping there investments inorder to offer new and improved products. This is expected to address critical and unmet needs of patients. This can be attributes by the fact that in August 2017, Jazz Pharmaceuticals, a key player in the market 3received FDA approval for Vyxeos, used for the treatment of acute myeloid leukemia.
On the flipside factors like need to improve functioning, toxicity issues and less solubility of nenopharmaceuticals are anticipated to hinder the nanapharmaceuticals market growth in the coming period.
Nevertheless, growth is nanopharmaceuticals market is fuel by increasing incidences of cardiovascular diseases, cancer, infectious diseases, and advantages of nanopharmaceuticals other conventional medicines.
Global Nanopharmaceuticals Market: Regional Outlook
The global nanopharmaceuticals market is divided into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. The global nanopharmaceticals market in North America is likely to grow at a significant pace during the forecast period. This is mainly due to the significant rise in research and development activities in the region and early adoption of advanced therapeutics. Apart from this, presence of key players is another factor behind the fast track growth of the nanopharmaceuticals market. The revenue generated by these players in the region is expected to boost the nanopharmaceuticals market.
Global Nanopharmaceuticals Market: Competitive Market
The competition in the nanopharmaceuticals market is fierce and intense owing to the presence of large number of players in the nanopharmaceuticals market. These players are adopting several strategies to stay ahead of each other. Some of them are mergers and acquisitions, business expansion, collaboration. Some of the key players operating in the global nanopharmaceuticals are JOHNSON & JOHNSON, Novartis AG, Merck & Co., Inc., Pfizer, Inc., Sanofi S.A, Hoffmann-La Roche AG, Shire Plc., and Teva Pharmaceuticals Industries Limited.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.